Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients
Clinical trial NCT00990938 · COMPLETED
Trial details
- NCT number
- NCT00990938
- Sponsor
- Idera Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-05-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.